Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Nanomedicine Advances – Clinical Challenges in Drug Delivery
- nanomedicine conference 2019

About Conference

Nanomedicine Conference 2019 will showcase the recent discoveries/advances performed towards the research in nanomedicine and healthcare system. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with world-class Scientists and Industry Professionals working in the field of Pharmaceutical sciences and Nanomedicine. It is a perfect platform to share knowledge to the implementation of those researchers to acquire the seamless Research &Scientific procedures.

Schedule-at-a-Glance
View a listing of all Nanomedicine conference sessions, events, and activities organized by date and time.
Oral and Poster Sessions
These sessions allow various communities to focus on specific topics of interest.
Trainee Activities 
These offerings are most relevant to the interests of trainees.
Policy and Conditions
Conference Policy and Conditions for swift planning.


Key-dates | Abstract Submission | Registration Guidelines

International Conference on Nanomedicine and Drug Delivery (Nanomedicine Conference 2019) aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Nanomedicine in Healthcare. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Nanomedicine. The conference program will cover a wide variety of topics relevant to the Nanomedicine, including: Nanomedicine in drug discovery and delivery, Nano diagnostics, theranostics, applications of Nanomedicine in healthcare applications and disease treatments.

Nanomedicine Conference 2019 has over 21 sessions designed to offer a comprehensive outlook that addresses current issues in Nanomedicine Research and in Healthcare System. Speakers are allocated specific slots corresponding to their session.

The abstract/s can be submitted online under Submit Abstract in Homepage or through e-mail at jessica.smith@alliedscholars.net


The completed registration/s is/are to be received per attendee and the corresponding payment in Dollar by the given deadlines. Please note that the registrations are available on-site too. But, we strongly emphasize to register in advance rather spot registration.

Outstanding Young Researcher Awards:
Each year, the Allied Academies offers the following merit-based award to support select trainees with high-achieving annual meeting abstracts who are selected to present their work at the Allied Academies annual meeting. Trainees include those who fall within one of the following categories: Graduates, Post Graduates and Research Scholars.

Abstract submission site opens

November 1, 2018

Abstract submission deadline

December 1, 2019, 11:59p.m. Pacific time


Late-breaking abstract submission site opens

December 7,2019


Scientific Sessions

The field of Nano Delivery now has pivotal roles inelectronics, biology and medicine. Its application can be appraised, as itinvolves the materials to be designed at atomic and molecularlevel. Due to theadvantage of their size, nanospheres have been shown to berobust drug deliverysystems and may be useful for encapsulatingdrugs and enabling more precisetargeting with a controlled release. In thisreview specifically, we highlightthe recent advances of this technology formedicine and drug delivery systems.  Nanomaterials rangefrom10–200 nm up to a few micrometres in size, and include nano- andmicroparticles, nanotubes and quantum dots.

Nanotechnological devices are madefrom metals, polymers, lipids and organic substances as well as frommacromolecules such as dendrimers, antibodies, micelles, liposomesandnanofibers. Nanomedicine makes use ofthese nanostructures fordiagnostic or therapeutic applications in allfields of medicine, using themfor drugdelivery, biosensors, neuro-electronicinterfaces, in vivoimaging, and cell-specific molecular interactions, where"cell repairmachines" could revolutionize medicine and the medicalfield. As drugdelivery systems, nanoparticles can be designedto improvethe pharmacological and therapeutic properties of drugs.The strengthof nanoparticulatedrug delivery systems is their ability to alter the pharmacokinetics andbiodistribution of drugs.

Track 1: Nanomedicine and Drug Delivery: 

Medication conveyance characterizes asthe best approach to take pharmaceutical fromthe diverse course of ogranization show in a human body andinaddition creature. At the point when the medication isgoneinto human or creature body begins to demonstrate some helpfulimpact, which mends our body, experience the ill effectsofparticular infection or sick. Medication will begin go from pharmacokinetics frameworkwhichcontain adsorption, digestion, dissemination and discharge andafterthat goes into the circulatory framework,wherethe particular medication reach to particular receptors and tiewiththe receptors, which begin recuperate to body. Medication conveyance hasdonefrom various course, e.g.; oral course, intravenous course,intramuscularcourse, transdermal patches, intraocularcourse,intra-peritoneal, suppositories, and so on

·        Targeted delivery

·        Nanoparticle formulation

·        Nanomedicinedelivery and inhalation aerosols

·        Self-emulsifying drugdelivery system

·        Oral and parental drugdelivery

NanomedicineConference | Drugdelivery Conference | NanomedicineMeeting | Drugdelivery Meeting | PharmaMeeting | pharmaceutical     Meeting | PharmaResearch | NanomedicineCongress | DrugdeliveryCongress | NanomedicineGathering | NanoMedicine | NanomedicineWorkshop | NanomedicineSymposium

Track 2:Drug Design and Drug Development:

Medication Design, regularly specific to as prudent pharmaceutical layout or justsensible arrangement, is that the imaginative system for finding new drugsmaintained the data of a natural sciences target. The medication is mostgenerally relate degree regular little particle that establishes or frustratesthe perform of a biomolecules like a macromolecules, that continuously ends upin a supportive advantage to the patient. Inside the unassuming sense, calmdiagram incorporates the organizing of particles that are reverse in casing andcharge to the bio sub-nuclear concentration with that they move and along theselines can attach to that. Solution blueprint of times anyway not fundamentallydepends upon convenient workstation showing systems. This sort of showing isroutinely observed as PC supported medication outline.

·       Drug Designing Docking

·       Types of Drug Design

·       Drug Targets

·       Structural based drugdesigning

·       Research &Development in Drug Designing.

NanomedicineConference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 3: Nanomedicine and Nanotechnology:

Nanotechnology forcancer is a field that incorporates the studies related to nanosized particles,their function and behavior with respect to different systems. The tremendouscapabilities of nanoparticles have changed the perspective and scope ofnanotechnology towards development into an adjuvant field for the remainingfields of life sciences. The role of nanotechnology in the field ofpharmaceutics has tremendously changed the way of our understanding aboutdrugs, nanodrugs or the use of nanoparticles as carrier of drug has become thebasic fundamental or criteria for the production or design of a drug andadvances in nanotechnology.

Nanotechnology is an important field of modern research dealing with design,synthesis, and manipulation of particle structures ranging from approximately1-100 nm.
The session Design of Nanomedicine and Nanotechnology includes broad topics like:  Carbon Nanotubes, Nanoparticles, Gold Nanoparticles, SilverNanoparticles, Magnetic Nanoparticles, Nano Micro Particles, NanocompositeMicrospheres, Biosensors and Nanobioelectronics, Bio inspired materials anddrug delivery and Nanobiomechanics and Nanomedicine.

NanomedicineConference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track4: Synthesis of Nanoparticles for Drug Delivery:

Nanoparticles (NPs)have wide range of applications in areas such as health care, cosmetics, foodand feed, environmental health, mechanics, optics, biomedical sciences,chemical industries, electronics, space industries, drug-gene delivery, energyscience, optoelectronics, catalysis, single electron transistors, lightemitters, nonlinear optical devices, and photo-electrochemical applications.

NanomedicineConference | Drugdelivery Conference | NanomedicineMeeting | Drugdelivery Meeting | PharmaMeeting | pharmaceuticalMeeting | PharmaResearch | NanomedicineCongress | Drugdelivery Congress | NanomedicineGathering | NanoMedicine | NanomedicineWorkshop | NanomedicineSymposium

Track5:  Regenerative Medicine and Tissue Engineering:

The promise of regenerativemedicine is truly remarkable. Regenerativemedicine is a new branch of medicine that attempts to change the course ofchronic disease, in many instances regenerating failing organ systems lost dueto age, disease, damage, or congenital defects. The area is rapidly becomingone of the most promising treatment options for patients suffering from tissuefailure.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 6: Nanomedicinein Theranostics:

Nanomedicineformulations aim to improve the biodistribution and the targetsite accumulation of systemically administered (chemo) therapeutic agents. Manydifferent types of nanomedicines havebeen evaluated over the years, including for instance liposomes, polymers,micelles and antibodies, and a significant amount of evidence has been obtainedshowing that these submicrometer-sized carrier materials are able to improvethe balance between the efficacy and the toxicity of therapeutic interventions.Besides for therapeutic purposes, nanomedicine formulations havein recent years also been increasingly employed for imaging applications.Moreover, paralleled by advances in chemistry, biology, pharmacy, nanotechnology, medicineand imaging, several different systems have been developed in the last decadein which disease diagnosis and therapy are combined. These so-called (nano)theranostics contain both a drug and an imaging agent within a singleformulation, and they can be used for various different purposes. In thisAccount, we summarize several exemplary efforts in this regard, and we showthat theranostic nanomedicines are highly suitable systems for monitoring drug delivery, drugrelease and drug efficacy. The (pre)clinically most relevant applications oftheranostic nanomedicines relate to their use for validating and optimizing theproperties of drug delivery systems, and to their ability to be used forpre-screening patients and enabling personalized medicine.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 7: Nanomedicine for Women’s Health Care:

Maintained medication conveyance has theplanned to enhance the treatment and avoidance of numerous conditions andailments that harass the female conceptive tract. Be that as it may,accomplishing compelling, remedial conveyance in the vaginal tract is tryingbecause of vaginal physiology. To conquer these issues, we are rising Nano medicine and novel conveyance vehicles that can give manageddischarge (enhancing adequacy) and convey tranquilizes consistently to the objectivesurface.

•        Breast cancer

•        Cervical and ovarian cancers

•        Global Health Challenges forPaediatric and Geriatric

•        HIV/AIDS and STDs/STIs: Vaccinesresearch and development

•        Nanomedicine for Gastrointestinaltract Diseases

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 8: Drug Delivery Research:

The main objective of ‘Drug Delivery’ research is to safely andefficiently target drugs orbioactive compounds to their site of action through the process of pharmaceutical formulation, utilisation of newtechnologies and systems. Most drugs and new bio-active molecules or agentssuch as probiotics, vaccines and pesticides are either insoluble or unstablewhich minimise their effectiveness. It is often necessary to incorporate theseagents into biocompatible formulations that canprotect them from degradation as well as making the delivery approach targetspecific, localised and more efficient. Novel drug delivery approaches usuallyresult in enhanced therapeutic efficiency as well as reduced side effects andcost.

•        Nanoformulation

•        Dosage form research

•        Pharmaceutical technology

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 9: Novel Drug Delivery Systems:

To minimize drug degradation and loss to preventharmful side-effects and to increase drug bioavailability and the fraction ofthe drug accumulated in the required zone, various drug delivery and drug targeting systems are currently underdevelopment. Among drug carriers one can name soluble polymers, microparticlesmade of insoluble or biodegradable natural and synthetic polymers,microcapsules, cells, cell ghosts, lipoproteins, liposomes, and micelles. Thecarriers can be made slowly degradable, stimuli-reactive (e.g., pH- ortemperature-sensitive), and even targeted (e.g., by conjugating them withspecific antibodies against certain characteristic components of the area ofinterest). Targeting is the ability to direct the drug-loaded system to thesite of interest. Two major mechanisms can be distinguished for addressing thedesired sites for drug release: (i) passive and (ii) active targeting. Anexample of passive targeting is the preferential accumulation of chemotherapeuticagents in solid tumors as a result of the enhanced vascular permeability oftumor tissues compared with healthy tissue. A strategy that could allow activetargeting involves the surface functionalization of drug carriers with ligandsthat are selectively recognized by receptors on the surface of the cells ofinterest. Since ligand–receptor interactions can be highly selective, thiscould allow a more precise targeting of the site of interest.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 10: Smart Drug Delivery Technology:

To maximize knowledge of the currentresearcher on developing drug delivery viaPharmaceutical formulation,  Smart Drug Delivery conference themed qualitytopics on Drug Targeting, Drug Designing, Drug evaluation, DrugDelivery andTherapeutics,  Biodegradable polymers,Dendrimer a versatile polymer in drug delivery are a uniquely architect sessionto play an important role in the fields of nanotechnology, pharmaceutical and medicinalchemistry.

Major drugs driving growth of the overallsmart drug delivery market include Angiomax, Copaxone, Forteo , Sandostatin,Velcade, Victoza and Zoladex.


•        Insitu Drug Delivery

•        Lymphoid Drug Delivery System

•        Hydrogel in Drug Delivery

•        Sonophoresis Drug Delivery System

•        Micelle Drug Delivery

•        Trans mucosal Drug DeliverySystems

•        Nano Biosensors

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 11: Nano Pharmaceuticals:

PharmaceuticalNanotechnology for Drug Delivery using Nanotechnology sessionplays major role in the future of pharmaceutical research. In this session, wewill go over several of the most important features of nanotechnology, anticancer drug development , pharmocologyof cancer drugs, that will impact our lives but we will also talk about whatnanotechnology itself will be like in the future and Investigator specificallyfrom cancer therapy. Interestingly pharmaceutical sciences are usingnanoparticles to reduce toxicity and side effects of drugs and up to recentlydid not realize that carrier systems themselves may impose risks to the patient.

Nanomedicine Conference | Drugdelivery Conference | Nanomedicine Meeting | Drugdelivery Meeting | Pharma Meeting | pharmaceutical Meeting | PharmaResearch | Nanomedicine Congress | Drugdelivery Congress | Nanomedicine Gathering | NanoMedicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 12: Biopharmaceutics and Biologic Drugs:

Biopharmaceutics is defined as the studyof factors influencing the rate and amount of drug that reaches the systemiccirculation and the use of this information to optimise the therapeuticefficacy of the drug products. The process of movement of drug from its site ofadministration to the systemic circulation is called as absorption. Theconcentration of drug in plasma and hence the onset of action, and theintensity and duration of response depend upon the bioavailability of drug fromits dosage form. Bioavailability isdefined as the rate and extent (amount) of drug absorption. Biologic Drugs, orbiologic response modifiers, are medications genetically engineered from aliving organism, such as a virus, gene or protein, to simulate the body’snatural response to infection and disease. Biologics target proteins, cells andpathways responsible for the symptoms and damage of rheumatoid arthritis andother types of inflammatory arthritis. Biologic response modifiers (biologicsfor short) are drugs that are genetically engineered from a living organism,such as a virus, gene or protein, to simulate the body’s natural response toinfection and disease.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 13: Nano Biotechnology:

Nanobiotechnology isrelatively new to medical, consumer, and corporate bodies. One example ofcurrent nanobiotechnological research involvesnanospheres coated with fluorescent polymers. Researchers are seeking to designpolymers whose fluorescence is quenched when they encounter specific molecules.Different polymers would detect different metabolites. The polymer-coated spheres could become partof new biological assays, and the technology might someday lead to particleswhich could be introduced into the human body to track down metabolitiesassociated with tumors and other health problems. Another example, from adifferent perspective, would be evaluation and therapy at the nanoscopic level,i.e. the treatment of Nanobacteria (25-200 nm sized) as is done by NanoBiotech Pharma.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 14: Nano Pharmaceutical Industry and Market:

Nano Pharmaceutical Industry Companies andMarket session is beginning to change for small, medium, and large scalepharmaceutical Co, biopharmaceutical Manufacturing and Industries, generic drugs companies, contract drug delivery companies which can manifestfrom development to manufacturing. Addressing these instabilities is a greatchallenge, because of the complexity of the Clinical bio therapeutics themselves. Thissession includes Rheological behaviour, Pharmaceutical Guidelines, Pharmaceutical companies and regulatoryguidelines perspectives, Advances in computational modeling forbioavailability, drug Stability of Pharmaceutical products which are drivingcrucial research into new vaccines and medicines. The pharmaceutical industryand the public sector are thinking differently than before about how to improveaccess to medicines and advance research anddevelopment for neglected diseases.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 15 : Clinical Translation in Nanomedicine and DrugDelivery:

The use of nanotechnology in medicine has thepotential to have a major impact on human health for the prevention, diagnosis,and treatment of diseases. One particular aspect of the nanomedicine fieldwhich has received a great deal of attention is the design and development of nanoparticulate nanomedicines (NNMs) fordrug delivery (i.e., drug-containing nanoparticles). NNMs are intended todeliver drugs via various mechanisms: solubilization, passive targeting, activetargeting, and triggered release. The NNM approach aims to increase therapeuticefficacy, decrease the therapeutically effective dose, and/or reduce the riskof systemic side effects. In order to move a NNM from the bench to the bedside,several experimental challenges need to be addressed. This review will discussthe current trends and challenges in the clinical translation of NNMs as wellas the potential pathways for translational development and commercialization.Key issues related to the clinical development of NNMs will be covered,including biological challenges, large-scale manufacturing, biocompatibility and safety, intellectualproperty (IP), government regulations, and overall cost-effectiveness incomparison to current therapies. These factors can impose significant hurdleslimiting the appearance of NNMs on the market, irrelevant of whether they aretherapeutically beneficial or not.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 16: Biomarkers Detection of Drug Delivery Systems :

These novel frameworks include utilization of Nanoparticles, super paramagnetic materials,protein biosensors, and propelled light helped atomic immobilizationinnovation. The gathering has obtained central information on light actuatedsystems in protein structures. Utilizing ultraviolet light it is conceivable toopen disulphide bonds in proteins prompting protein immobilization onto thiolresponsive surfaces (glass, quartz or gold surfaces).

•        Microarray

•        Protein Engineering

•        Genomic Biomarker Discovery

•        Molecular immobilizationtechnology

•        Big Data Analytics for BiomarkersDevelopment

•        Exosome-based drug deliverysystems

Applications of Imaging Biomarkers:

•        Biomarkers and drug deliveryapplications

•        Diagnosis and therapeutics

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 17: Nanotoxicity:

Nanotoxicology refers to the study of theinteractions of nanostructures withbiological systems with an emphasis on identifying the relationship between thephysical and chemical properties of nanostructures and induction of toxicbiological responses. A complete understanding of the relationship betweenunique properties of nanostructures and in vivo and in vitro behaviors willprovide a strong basis for assessing toxic responses. Studies in animal modelswill identify the organs of interest, in turn leading to identification of thebest cell types for in vitro cytotoxicity studiesto further enhance our understanding of how these cells molecularly respond tothe nanostructures. Toxicologic tests and the resulting database would provideinformation for material safety data sheets for nanoparticles as well as abasis for risk assessment and management.

•        Oxidative stress

•        Cytotoxicity

•        Genotoxicity

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 18: Nanofabrication:

The development of nanotechnology depends onthe ability to build and maneuver structures at the scale of 10-100 nanometers(nm). Traditionally, engineers have fabricated nanometer-sized structuresthrough a “top-down” approach by “carving them out” via lithography from alarge substrate. Substantial and growing capital investment is required forsuch fabrication techniques. Alternatively, a“bottom-up” approach, relying on the self-assembly of atomic and molecularspecies into nanoscale structures through chemical processes, may hasten thedevelopment of future nanotechnology products by providing a cost-effectiveroute to the production of uniform nanostructures on large scales.

•        Electron beam lithography

•        Focused ion beam lithography

•        Colloid monolayer lithography

•        Molecular self  assembly

•        Electrically inducednanopatterning

•        Rapid prototyping

•        X-ray lithography

•        Ion projection lithography

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 19: Impact of Nanomedicine on Health Care:

The use of nanotechnology to human social insurance,offers various potential pathways to enhancing therapeutic determination andtreatment and even to recover tissues and organs. It can totally change thehuman services segment for the people to come. Nanotechnology will help medicinal expertsin the present most intense therapeutic issues, for example, repairing ofharmed organs, conclusion and treatment of disease cells, expulsion of obstaclein cerebrum and it can help in better medication conveyance framework. Nanotechnology can be utilized for both invivo and in vitro biomedical research andapplications. Nano particles can be utilized as a part of focusing on tumorcells at beginning stage. Nanotechnology can be utilized to create ''signatureprotein'' to treat tumor. 

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 20: Future Concepts in Nanomedicine:

Nanomedicine ispromising remarkable things including great advancements in the treatment ofcancer. Imagine a world where there is no donor organ shortage. Where victimsof spinal cord injuries can walk, where weakened hearts are replaced. This isthe long-term promise of regenerative medicine, a rapidly developing field withthe potential to transform the treatment of human disease through thedevelopment of innovative new therapies that offer a faster, more completerecovery with significantly fewer side effects or risk of complications.

Nanomedicine Conference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Track 21: Pharmaceutical Marketing:

Pharmaceuticalmarketing is the lastelement of an information continuum, where research concepts are transformedinto practical therapeutic tools and where information is progressively layeredand made more useful to the health care system. Thus, transfer of informationto physicians through marketing is a crucial element of pharmaceuticalinnovation. By providing an informed choice of carefully characterized agents,marketing assists physicians in matching drug therapy to individual patientneeds. Pharmaceutical marketing is presently the most organized andcomprehensive information system for updating physicians about the availabilitysafety, efficacyhazards, and techniques ofusing medicines. The costs of pharmaceutical marketing are substantial,but they are typical of high-technology industries that must communicateimportant and complex information to sophisticated users. These costs areoffset by savings resulting from proper use of medicines and from lower drugcosts owing to price competition.

Pharmaceuticalcompany spending on marketing far exceeds that of itsresearch budget. In Canada, $1.7 billion was spent in 2004 to market drugs tophysicians; in the United States, $21 billion was spent in 2002. In 2005, moneyspent on pharmaceutical marketing in the United States was estimated at $29.9billion with one estimate as high as $57 billion. When the U.S. numbers arebroken down, 56% was free samples, 25% was pharmaceutical sales representative"detailing" (promoting drugs directly to) physicians, 12.5% wasdirect to user advertising, 4% on detailing to hospitals, and 2% on journal ads.

NanomedicineConference | Drug delivery Conference | Nanomedicine Meeting | Drug delivery Meeting | Pharma Meeting | pharmaceutical Meeting | Pharma Research | Nanomedicine Congress | Drug delivery Congress | Nanomedicine Gathering | Nano Medicine | Nanomedicine Workshop | Nanomedicine Symposium

Market Analysis

Market Analysis In UAE:

The U.A.E. pharmaceutical market is the second-largest in the Gulf Cooperation Council (GCC) after Saudi Arabia.  Business Monitor International (BMI) estimates the U.A.E. pharmaceutical market reached a value of $2.6 billion in 2016, representing 16.3 percent of healthcare expenditure and 0.7 percent of GDP.  For 2017, BMI projects year-over-year growth of 8.5 percent.  Market dynamics – including rapid approval times, increasing insurance penetration and a strong patented drug market – will ensure the country's pharmaceutical market remains of interest to innovative drug makers.

The U.A.E. imports pharmaceutical products from 72 countries, and 10 countries account for approximately 80 percent of the entire supply:  United Kingdom, Switzerland, Germany, Belgium, USA, France, Spain, Italy and Australia. Most major research-based firms have a long-standing presence in the U.A.E., either via contract manufacturing or local distribution channels.  Leading multinationals include Pfizer, Novartis, Sanofi, GlaxoSmithKline (GSK), Bayer, AstraZeneca, Merck, Abbvie, Eli Lily, BMS, and Amgen. 

The domestic sector is small.  Currently, the local manufacturing industry’s clear leader is Gulf Pharmaceutical Industries, followed by Neopharma, Global Pharma, specialty generic injectable maker Gulf Inject, and Julphar Pharmaceuticals.  In January 2017, the U.A.E.’s Ministry of Health (MoH) announced plans to increase the number of pharmaceutical manufacturing facilities to 30 by 2020 – up from 16 in 2017.  The U.A.E. government has taken continuous measurements to ensure long-term growth for this key sector. Beyond revisiting the drug approval processes, the MoH intends to work with local companies to improve the licensing policy for existing drug manufacturers. 

As of August 2016, the MoH cut the prices of 762 innovative and critically required medicines by up to 66 percent as part of the seventh initiative of “Reduction in Medicine Prices”.  During 2016, MOHAP allocated approximately AED 462 million ($125 million) for procurement of medicines and medical supplies in order to ensure an uninterrupted supply. 

The country's accelerated drug-registration system applies to both innovative and generic medicines that have been approved by the U.S. Food & Drug Administration. Recent examples of fast-tracked products in the U.A.E. include Eli Lilly's Trulicity (dulaglutide), AbbVie's Viekirax (ombitasvir/paritaprevir/ritonavir), and Exviera (dasabuvir) for hepatitis C.  

The MoH has warned against the rise of counterfeit drugs online and the ministry is currently keeping a close monitoring on websites suspected of this activity. According local media, most of the counterfeit drugs sold online and smuggled into countries are medicines used to treat chronic diseases such as diabetes, hypertension and obesity.

Leading Sub-Sectors:

In June 2017, the Ministry of Health (MoH) signed a memorandum of understanding with Jebel Ali Free Zone Authority (Jafza) for the development of the pharmaceutical and healthcare sector, with a particular focus on reducing the regulatory barriers. As part of the agreement, the UAE states it is aiming to attract 75 innovative drug makers to the Jebel Ali free zone by 2021, with the number of companies producing patented drugs locally expected to double.

UAE pharma market to top $3.8bn by 2020:

The pharmaceutical market in the UAE is expected to grow from Dh9.61 billion ($2.6 billion) in 2016 to Dh14.11 billion ($3.84 billion) by 2020, driven by increased healthcare spend, mandatory health insurance and growing medical tourism.

This was stated by the participants in the Pharmaceutical Research & Manufacturers Association Gulf Forum, PhRMAG 2017, which is being held in Dubai under the patronage of Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai and UAE Minister of Finance, and president of the Dubai Health Authority, reported Wam, the Emirates news agency.

In its maiden edition, the Forum is running under the theme "Enhancing Knowledge-Based Economy to Advance Human Health," bringing together private and public sector stakeholders to examine the most pressing issues concerning patients, healthcare providers and the biopharmaceutical sector while also exploring the role of innovative medicines in terms of saving lives, reducing mortality rates and mitigating expensive hospitalisations for patients. Delivering the event's inaugural speech, Humaid Al Qutami, chairman of the Board and director-general of the Dubai Health Authority, said that great strides have been made in the pharmaceutical industry across the GCC region over the past decades, with Gulf pharmaceutical companies managing to keep pace with the rapid and multi-faceted changes occurring worldwide in the healthcare scene by forming robust partnerships with key players in the market.

Dr Amin Hussein Al Amiri, assistant under-secretary for Public Health Policy and Licensing Sector, UAE Ministry of Health and Prevention, MOHAP, offered his insights on a topic titled, "The innovative biopharmaceutical industry invests in research and development and capital improvements, what are the opportunities for the Gulf countries in this strategic, dynamic sector?"

"In keeping with the directives of the country's wise leadership and the National Strategy for Innovation, the Ministry of Health and Prevention is sparing no efforts to provide healthcare services that prioritise safety of patients in the first place," he said, affirming the ministry's unshakable commitment to providing best healthcare services to the people of the UAE in line with best international practices and standards.

PhRMAG Forum 2017 is witnessing the participation of nearly 200 delegates with 10 expert speakers and specialists coming from the UAE and abroad to primarily focus on the "Value of partnership between PhRMAG and various other key stakeholders" in delivering the best quality healthcare systems for patients in the UAE.

UAE sets out plan to become major global pharma hub: 

Country aims to double number of drugs manufacturing factories by 2021, attract more pharma firms. The UAE has unveiled plans to establish itself as a global hub for international pharmaceutical companies, with the number of manufacturing factories set to double by 2021. The UAE Ministry of Health and Prevention and Jafza, a DP World company, have signed a memorandum of understanding for the development of the healthcare and pharmaceutical sector in the country. Under the agreement, the UAE aims to attract more than 75 major pharmaceutical firms by 2021 up from the current 54 today, with investments of up to AED2 billion annually. The number of drugs manufacturing factories is expected to grow from 17 to 34 in the same period. The agreement is part of Jafza’s efforts to enhance the healthcare sector by providing the environment for companies to grow and establish Made in Dubai pharmaceutical products, a statement said. It added that Jafza will develop details for the licensing of pharmaceutical factories within the Free Zone and help them promote public health. Both organisations said they will exchange knowledge and remove any barriers to the development of the pharmaceutical sector in the Free Zone. They will also review the process of obtaining approvals and permits from the Ministry, enabling Jafza to attract more foreign investment in the sector. DP World Group chairman and CEO, Sultan Ahmed bin Sulayem, said: “This is a major step forward in efforts to raise the competitiveness of the pharmaceutical industry in the country. "The ultimate aim is to manufacture high quality medicines and healthcare products in Dubai comparable to those around the world with our focus on boosting investment in research and development, and attracting qualified professionals.” In 2016, the market value of drugs in the UAE amounted to AED9.61 billion. By 2020, spending on medicine is expected to reach AED13.13 billion and by 2025 AED21.74 billion, driven by population growth, changing morbidity and the use of modern medicines such as biotechnology drugs, the statement said. Multinational companies in the healthcare and pharmaceutical sector are currently based in Jafza, such as Johnson & Johnson, Colgate, Roche, Sanofi, GlaxoSmithKline and Quest Vitamins.


                                                                 

 

To Collaborate Scientific Professionals around the World

Conference Date December 9-10, 2019
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

Accommodations will be provided at Conference Venue:
RADISSON BLU HOTEL, ABU DHABI YAS ISLAND
Golf Plaza Yas Island P.O. Box 93725 
Abu Dhabi United Arab Emirates
 

Image result for RADISSON BLU HOTEL, ABU DHABI YAS ISLAND

Join The Discussion

Contact Desk

Program Manager

Jessica Smith

jessica.smith@alliedscholars.net

+44 800 086 8979

Sponsorship/Exhibitor Opportunity

Sofia Marry

sponsors@alliedscholars.com

+1 800-858-2189

General Enquiry

info@alliedscholars.com

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Allied Academies Global Conference Directory

Mail us at

Program Manager
jessica.smith@alliedscholars.net
Sponsorship/Exhibitor Opportunity
sponsors@alliedscholars.com
General Enquiry
info@alliedscholars.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

 

Insurance

No insurance, of any kind, is included along with the registration in any of the events of the organization.

 

Transportation

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

 

Press/Media

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.

 

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact jessica.smith@alliedscholars.net to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.

 

Cancellation Policy

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

 

If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Postponement of event

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to finance@alliedacademies.com. Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

 

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

  • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

 

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

Highlights from last year's Convention

Authorization Policy


Copyright © 2019-2020 Allied Academies, All Rights Reserved.